Riskpilot← Back to searchSign inGet full accessABBEX AB
ABActiveOrg 5566231782SolnaActivities of agents involved in the wholesale of other particular products · NACE 4618Est. 20020 employees
Revenue 2024
SEK 0
EBITDA margin
—
+3561% vs 2023
Equity ratio
0.0%
Financial strength
Net profit 2024
SEK -1,7M
-143% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK 259M | +3561% |
| Net profit | SEK -1,7M | -143% |
| Total assets | SEK 706,8M | +67% |
| Equity | SEK 240K | -88% |
| Employees | 0 | — |
Legal name
ABBEX AB
Org number
5566231782
Legal form
Aktiebolag
NACE code
4618 · Activities of agents involved in the wholesale of other particular products
Founded
1 februari 2002
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall exploatera och försälja patent och licensrättigheter inom hälso- och sjukvårdsområdet. Bolaget ska också idka försäljning, behandling, rådgivning och utbildning samt bedriva produktutveckling i anslutning därtill ävensom idka därmed förenlig verksamhet.
Address
Solna
Phone
+4686301900
Email
info@abbex.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 71 087 | 55 829 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 16 587 | 26 702 | 58 889 | 40 206 | 60 828 | 64 300 | 81 035 | 8 683 | 7 074 | 259 010 |
| Depreciation & amort. | −161 | −643 | −680 | −680 | −680 | −680 | −680 | −680 | −680 | −158 |
| EBIT | 16 426 | 26 059 | 58 209 | 39 526 | 60 148 | 63 620 | 80 355 | 8 003 | 6 394 | 258 852 |
| Net financials | 1 490 | −750 | 60 | −1 026 | −447 | −6 | 39 | −281 | −178 | −2 406 |
| Profit before tax | 0 | 0 | 0 | 0 | −639 | −46 | −639 | −959 | −857 | −1 629 |
| Tax | −0 | −0 | −0 | −0 | 132 | −0 | 140 | 148 | 140 | −112 |
| Net profit | 0 | 0 | 58 269 | 0 | −507 | −46 | −499 | −811 | −717 | −1 741 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 80 733 | 95 691 | 151 634 | 205 643 | 241 374 | 322 353 | 409 890 | 392 435 | 423 953 | 706 798 |
| Equity | 4 562 | 4 562 | 4 562 | 4 562 | 4 055 | 4 009 | 3 510 | 2 699 | 1 981 | 240 |
| Long-term debt | 27 714 | 74 603 | 132 761 | 187 114 | 237 309 | 302 255 | 386 122 | 389 723 | 421 872 | 706 445 |
| Short-term debt | 48 457 | 16 526 | 14 311 | 13 967 | 10 | 16 088 | 20 257 | 13 | 99 | 113 |
| Total debt | 76 171 | 91 129 | 147 072 | 201 081 | 237 319 | 318 343 | 406 379 | 389 736 | 421 971 | 706 558 |
EBITDA margin
25901000000.0%
This company
15.8%
Market median
+163930379647% vs market
20152024
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20152024
Return on equity
-725.4%
This company
18.4%
Market median
-4042% vs market
20152024
Net profit margin
-174100000.0%
This company
8.1%
Market median
-2149382816% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
2943.99×
This company
0.62×
Market median
-474737% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AP Chief Auditor | Chief Auditor | 2022 | — | — |
VS Chief Auditor | Chief Auditor | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Ipex AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bgp Products AB
ABBEX AB Board members of ABBEX AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arne Pontus Pålsson | Chief Auditor | 0 companies |
| Vidar Sie | Chief Auditor | 0 companies |
| Lars Henrik Andreas Rejnus | Chairman | 0 companies |
| Bernard Christiaan Spoelstra | Chairman | 0 companies |
| Caroline Rebecca Louise Dixon | Board of Directors | 0 companies |
| Jenny Friberg | Board of Directors | 0 companies |
| Jan-Christer Stefan Engryd | Board of Directors | 0 companies |
| Jose Javier Cotarelo | Board of Directors | 0 companies |